You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

salvage chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

Not yet recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • (no location specified)
May 24, 2023

Melanoma Trial in Beijing, Nanjing, Hangzhou (OH2, Salvage chemo or best supportive care)

Recruiting
  • Melanoma
  • OH2
  • Salvage chemotherapy or best supportive care
  • Beijing, Beijing, China
  • +2 more
May 11, 2023

Large Cell Lymphoma, Diffuse, Relapsed Cancer, Refractory Cancer Trial (AutoSCT, GDP, Epcoritamab)

Not yet recruiting
  • Large Cell Lymphoma, Diffuse
  • +2 more
  • AutoSCT
  • +2 more
  • (no location specified)
May 10, 2023

Chemo Effect, Rectal Cancer Trial in Guangzhou (Radical total mesorectal excision, Salavge Adjuvant Chemoradiotherapy)

Recruiting
  • Chemotherapy Effect
  • Rectal Cancer
  • Radical total mesorectal excision
  • Salavge Adjuvant Chemoradiotherapy
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Sep 12, 2023

Classical Hodgkin Lymphoma Trial in Cologne (Pembrolizumab plus Chemotherapy (ICE or DHAP))

Not yet recruiting
  • Classical Hodgkin Lymphoma
  • Pembrolizumab plus Chemotherapy (ICE or DHAP)
  • Cologne, Germany
    1st Department of Medicine, Cologne University Hospital
Aug 5, 2022

Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

Not yet recruiting
  • Leukemia, Acute Myeloid (AML)
  • (no location specified)
Oct 16, 2022

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed B-Cell Lymphoma Trial in Saint Louis (Mosunetuzumab,

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 14, 2022

Classical Hodgkin Lymphoma Trial in China (Tislelizumab, Salvage Chemotherapy)

Recruiting
  • Classical Hodgkin Lymphoma
  • Beijing, Beijing, China
  • +6 more
Jan 4, 2022

Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028, Salvage Chemotherapy)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Chengdu, Sichuan, China
    West China hospital of Sichuan University
Nov 1, 2021

Hodgkin Lymphoma, Adult, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Caba (Evaluation of

Recruiting
  • Hodgkin Lymphoma, Adult
  • +2 more
  • Evaluation of therapeutical approach after ASCT
  • Caba, Argentina
    FUNDALEU
Oct 1, 2021

Esophageal Tumor Metastatic, Esophageal Cancer Stage IVb Trial in Beijing (drug, biological, radiation)

Recruiting
  • Esophageal Neoplasm Metastatic
  • Esophageal Cancer Stage IVb
  • TP (Paclitaxel with cisplatin or carboplatin) or PF (Fluoropyrimidine with cisplatin or carboplatin) regimen depended on investigator's choice.
  • +3 more
  • Beijing, Beijing, China
    Cancer hospital, CAMS
Oct 19, 2023

Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Lexington (Pentamidine)

Completed
  • Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Jul 6, 2021

MDS, Leukemia, Myeloid, Acute, Leukemia, Relapsed Adult Acute Myeloid Trial in New York (CPX-351, Fludarabine, Melphalan)

Active, not recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • New York, New York
    Weill Cornell Medical College
Jan 26, 2022

Diffuse Large B Cell Lymphoma Trial in Poland (Ofatumumab, Etoposide, Ifosfamid)

Completed
  • Diffuse Large B Cell Lymphoma
  • Wrocław, Dolnośląskie, Poland
  • +7 more
Dec 23, 2021

Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Trial in Worldwide (gilteritinib, LoDAC (Low Dose

Active, not recruiting
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
  • Beijing, China
  • +47 more
Aug 17, 2022

Hodgkin's Lymphoma Trial in Poland (drug, diagnostic test, procedure)

Recruiting
  • Hodgkin's Lymphoma
  • Bydgoszcz, Poland
  • +12 more
Dec 23, 2021

Biliary Tract Cancer Trial in Seoul (Pemetrexed 500 MG, Erlotinib)

Recruiting
  • Biliary Tract Cancer
  • Seoul, Korea, Republic of
  • +1 more
Jun 13, 2022

Esophageal Squamous Cell Carcinomas Trial (PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1

Not yet recruiting
  • Esophageal Squamous Cell Carcinomas
  • PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
  • (no location specified)
Nov 1, 2021

Prostate Cancer Trial in United States (Vinflunine)

Completed
Has Results
  • Prostate Cancer
  • Fort Myers, Florida
  • +11 more
Dec 14, 2021

Gastric Adenocarcinoma, Malignant Melanoma Trial in Seoul (AZD6738, Durvalumab)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Malignant Melanoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Relapsed or Refractory Acute Myeloid Leukemia Trial in France (Dexamethasone, Amsacrine, Cytarabine)

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Grenoble, France
  • +7 more
Jul 29, 2020

DLBCL Trial in Rotterdam (R-DHAP, Brentuximab Vedotin)

Recruiting
  • DLBCL
  • R-DHAP
  • Brentuximab Vedotin
  • Rotterdam, Netherlands
    NL-Rotterdam-ERASMUSMC
Dec 9, 2020

Acute Myeloid Leukemia Trial in Praha (OmnImmune®)

Completed
  • Acute Myeloid Leukemia
  • OmnImmune®
  • Praha, Czechia
    UHKT (Ustav hematologie a krevni transfuze)
Mar 29, 2021

Esophageal Squamous Cell Carcinoma Trial in Norway, Sweden (radiation, drug, procedure)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Neoadjuvant radiotherapy (arm A)
  • +5 more
  • Oslo, Norway
  • +8 more
Mar 29, 2022

Leukemia, Acute Myeloid (AML) Trial in Worldwide (gilteritinib, LoDAC (Low Dose Cytarabine), Azacitidine)

Active, not recruiting
Has Results
  • Leukemia, Acute Myeloid (AML)
  • Birmingham, Alabama
  • +125 more
Aug 9, 2022